Drug Profile
Finasteride/tamsulosin - Merck
Alternative Names: MK-0906ALatest Information Update: 04 Jul 2016
Price :
$50
*
At a glance
- Originator Merck Sharp & Dohme
- Class Amines; Androstenes; Antiandrogens; Antineoplastics; Azasteroids; Benzene derivatives; Ethers; Small molecules; Sulfonamides
- Mechanism of Action Alpha-1a adrenergic receptor antagonists; Cholestenone 5-alpha reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Benign prostatic hyperplasia
Most Recent Events
- 29 Sep 2014 No development reported - Preclinical for Benign prostatic hyperplasia in USA (PO)
- 29 Sep 2011 Preclinical trials in Benign prostatic hyperplasia in USA (PO)